![]() Brain regulation of emotional conflict differentiates response to antidepressants versus placebo in depression. Establishing moderators and biosignatures of antidepressant response in clinical care (EMBARC): rationale and design. ![]() An information-maximization approach to blind separation and blind deconvolution. On the interpretation of weight vectors of linear models in multivariate neuroimaging. Deep learning with convolutional neural networks for EEG decoding and visualization. Bayesian machine learning: EEG/MEG signal processing measurements. Machine learning for real-time single-trial EEG-analysis: from brain–computer interfacing to mental state monitoring. Electric Fields of the Brain: The Neurophysics of EEG (Oxford Univ. Changes in brain function of depressed subjects during treatment with placebo. Rostral anterior cingulate cortex theta current density and response to antidepressants and placebo in major depression. Pretreatment rostral anterior cingulate cortex theta activity in relation to symptom improvement in depression: a randomized clinical trial. Leveraging machine-learning approaches for predicting antidepressant treatment response using electroencephalography (EEG) and clinical data. Jaworska, N., de la Salle, S., Ibrahim, M.-H., Blier, P. EEG biomarkers in major depressive disorder: discriminative power and prediction of treatment response. Electroencephalographic biomarkers for treatment response prediction in major depressive Illness: a meta-analysis. Using electroencephalography for treatment guidance in major depressive disorder. Initial severity and antidepressant benefits: a meta-analysis of data submitted to the food and drug administration. The Emperor’s New Drugs: Exploding the Antidepressant Myth (Random House, 2009). Antidepressants versus placebo in major depression: an overview. Antidepressant drug effects and depression severity: a patient-level meta-analysis. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Resting-state connectivity biomarkers define neurophysiological subtypes of depression. Our findings advance the neurobiological understanding of antidepressant treatment through an EEG-tailored computational model and provide a clinical avenue for personalized treatment of depression.ĭrysdale, A. Furthermore, we found that the sertraline resting-state EEG signature indexed prefrontal neural responsivity, as measured by concurrent transcranial magnetic stimulation and EEG. This sertraline-predictive EEG signature generalized to two depression samples, wherein it reflected general antidepressant medication responsivity and related differentially to a repetitive transcranial magnetic stimulation treatment outcome. Symptom improvement was robustly predicted in a manner both specific for the antidepressant sertraline (versus placebo) and generalizable across different study sites and EEG equipment. We designed a latent-space machine-learning algorithm tailored for resting-state electroencephalography (EEG) and applied it to data from the largest imaging-coupled, placebo-controlled antidepressant study ( n = 309). Here, we sought to identify a neurobiological signature of response to antidepressant treatment as compared to placebo. Nature Biotechnology volume 38, pages 439–447 ( 2020) Cite this articleĪntidepressants are widely prescribed, but their efficacy relative to placebo is modest, in part because the clinical diagnosis of major depression encompasses biologically heterogeneous conditions. ![]() An electroencephalographic signature predicts antidepressant response in major depression
0 Comments
Leave a Reply. |